Related Experiment Video
Updated: Sep 4, 2025

07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
19.9K
Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes
Thomas Robbins1, Tanya L Hoskin1,2, Courtney N Day2
1Division of Breast and Melanoma Surgical Oncology, Mayo Clinic, Rochester, MN, USA.
Annals of Surgical Oncology
|July 19, 2022
Summary
Patients with suspicious lymph nodes on ultrasound but negative fine needle aspiration (FNA) have a low risk of positive nodes, similar to those with negative ultrasounds. Routine excision of clipped nodes is not necessary.
Area of Science:
- Oncology
- Radiology
- Surgical Pathology
Background:
- Fine needle aspiration (FNA) aids breast cancer staging and neoadjuvant therapy decisions.
- Limited data exists for suspicious lymph nodes that are FNA negative.
- This study compares node positivity rates between negative axillary ultrasound (AUSneg) and suspicious ultrasound with negative FNA (FNAneg).
Purpose of the Study:
- To compare the frequency of axillary lymph node positivity.
- To evaluate patients with negative axillary ultrasound (AUSneg) versus suspicious ultrasound with negative FNA (FNAneg).
Main Methods:
- Retrospective analysis of clinically node-negative (cN0) invasive breast cancer patients treated with upfront surgery (2016-2021).
- Comparison of clinicopathologic characteristics and nodal positivity rates between AUSneg and FNAneg groups.
- Analysis included patients undergoing FNA of suspicious lymph nodes.
Main Results:
- 1580 patients analyzed: 1240 AUSneg and 340 FNAneg.
- FNAneg group was younger and had higher clinical T category.
- Axillary pathologic node positivity did not differ significantly (16.5% AUSneg vs. 19.1% FNAneg, p=0.25).
Conclusions:
- Patients with suspicious lymph nodes and negative FNA have a low chance of positive nodes, similar to those with negative ultrasounds.
- Routine targeted excision of FNA-negative clipped nodes is not warranted.
- Findings support current clinical staging and treatment guidance for breast cancer patients.

